CN Patent

CN106999483B — 一种含有喹啉衍生物或其盐的药物组合物

Assigned to Shanghai Maijin Biomedical Technology Co ltd · Expires 2019-05-03 · 7y expired

What this patent protects

一种药物组合物，含有4‑[3‑氯‑4‑(环丙基氨基羰基)氨基苯氧基]‑7‑甲氧基‑6‑喹啉甲酰胺或其药理学上可接受的盐；以及碱性氨基酸或葡甲胺，和/或选自碳酸钾、碳酸氢钾中的至少一种化合物；且所述组合物不含有微晶纤维素。

USPTO Abstract

一种药物组合物，含有4‑[3‑氯‑4‑(环丙基氨基羰基)氨基苯氧基]‑7‑甲氧基‑6‑喹啉甲酰胺或其药理学上可接受的盐；以及碱性氨基酸或葡甲胺，和/或选自碳酸钾、碳酸氢钾中的至少一种化合物；且所述组合物不含有微晶纤维素。

Drugs covered by this patent

Patent Metadata

Patent number
CN106999483B
Jurisdiction
CN
Classification
—
Expires
2019-05-03
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Maijin Biomedical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.